Community-Acquired Bacterial Pneumonia: Developing Drugs for Treatment

Issue Date: January 10, 2014
Issued by: Center for Drug Evaluation and Research
Topic(s): Clinical – Antimicrobial
Status: Final

Community-Acquired Bacterial Pneumonia: Developing Drugs for Treatment

Community-Acquired Bacterial Pneumonia: Developing Drugs for Treatment This guidance does not discuss the general issues of statistical analysis or clinical trial design. Those topics are addressed in the ICH guidances for industry E9 Statistical Principles for Clinical Trials (September 1998) and E10 Choice of Control Group and Related Issues in Clinical Trials (May 2001), respectively.

Download the Guidance Document

webmaster2026-08-05T18:59:14+00:00

ABOUT US

Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) providing CGMP and GLP-compliant analytical and bioanalytical services to support drug development. From early discovery through clinical development and commercialization, we provide CGMP and GLP-compliant services tailored to your therapeutic modality and regulatory needs.